Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia
oleh: Yea-Yuan Chang, Yuag-Meng Liu, Chang-Pan Liu, Shu-Chen Kuo, Te-Li Chen, Yea-Yuan Chang, Yuag-Meng Liu, Shu-Chen Kuo, Chang-Pan Liu, Te-Li Chen, Yi-Tzu Lee, Ya-Sung Yang
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2018-02-01 |
Deskripsi
The higher 14-day mortality rate for patients with Acinetobacter bacteremia receiving tigecycline appropriately compared to other appropriate antibiotics (36.4% versus 14.2%, P = 0.028) was due to the poor effect of tigecycline for isolates with a minimum inhibitory concentration of 2 μg/mL (63.6% of 11 versus 14.2% of 127, P = 0.001).